Mastery EAQ Ch. 20

A  Administer after meals.

B  Administer after dissolving in water.

C  Administer with fruit juices.

D  Administer 30 minutes before meals.

A  Hyperthyroidism, Coronary artery disease, Emphysema, Type 2 diabetes mellitus

B  Peptic ulcer, Parkinsonism, Hyperthyroidism, Coronary artery disease

C  Emphysema, Type 2 diabetes mellitus, Peptic ulcer, Parkinsonism,

D  Emphysema, Type 2 diabetes mellitus, Parkinsonism, Hyperthyroidism,

A  “This medication will increase your ability to sleep without dreaming.”

B  “This medication should cure your Alzheimer’s disease.”

C  “This medication will enhance your memory.”

D  “You will only need to take this medication for 3 months.”

A  Lidocaine

B  Atropine

C  Epinephrine

D  Dopamine

A  Pupil constriction

B  Elevated heart rate

C  Decreased heart rate

D  Pupil dilation

A  Increased muscle strength

B  Moist oral mucous membranesn

C  Relief of dry skin

D  Improved vision

A  Able to walk long distances

B  Improved memory

C  No longer dizzy

D  Increased muscle strength

A  Hypertension and Syncope

B  Constipation and Mydriasis

C  Hair loss and Mydriasis

D  Hair loss and Constipation

A  Administration of a second drug

B  Assessment of bowel sounds

C  Assessment of blood pressure

D  Administration of another dose in an hour

A  Decreased gastric motility and Decreased sweat gland secretion

B  Decreased gastric motility and Pupil dilation

C  Decreased heart rate and Increased respiratory secretions

D  Pupil dilation and Decreased sweat gland secretion

A  “I will take the medication 30 minutes before meals.”

B  “The medical alert in my health care record should cover me.”

C  “I hope to feel improvement in muscle strength.”

D  “I will review any over-the-counter medications with my health care provider.”

A  Add more stimuli to the environment

B  A walking program at least once a week

C  Limit sleep during the day

D  Increased responsibility for self-care

A  Cardiovascular status, Gastrourinary (GU) status, Pain assessment, Complete blood count

B  Pain assessment, Complete blood count, Gastrourinary (GU) status, Assess for suicidal tendencies

C  Neurologic status, Cardiovascular status, Gastrourinary (GU) status, Assess for suicidal tendencies

D  Cardiovascular status, Pain assessment, Complete blood count, Neurologic status

A  Ataxia and Cramps

B  Diarrhea and Syncope

C  Ataxia and Bleeding

D  Bleeding and Cramps

A  Get up slowly. Eat something if you feel nauseated. Stop the medication if you have headaches. Tell your health care provider if you have stomach pains.

B  Stop the medication if you have headaches. Eat something if you feel nauseated. You may have some trouble sleeping. Tell your health care provider if you have stomach pains.

C  Get up slowly. Eat something if you feel nauseated. You may have some trouble sleeping. Tell your health care provider if you have stomach pains.

D  Get up slowly. Eat something if you feel nauseated. You may have some trouble sleeping. Stop the medication if you have headaches.

A  Urinary retention from neurogenic atony of the bladder

B  Peptic ulcer and nonobstructive urinary retention

C  Decreased urination with possible renal calculi

D  Post orthopedic surgery, low urinary output and bronchial wheezing

A  An antidote to tricyclic antidepressant toxicity. Relieve severe constriction of the bronchioles. Treat a patient with a prolonged history of sleep deprivation

B  Diagnose and treat myasthenia gravis. An antidote in biochemical warfare. An antidote to tricyclic antidepressant toxicity

C  Relieve severe constriction of the bronchioles. Treat a patient with a prolonged history of sleep deprivation. An antidote in biochemical warfare

D  Relieve severe constriction of the bronchioles. Diagnose and treat myasthenia gravis. Treat a patient with a prolonged history of sleep deprivation

A  “Do not take the medication if you feel tired.”
“Take the medication on an empty stomach.”
“Get up slowly from a sitting or lying position.”

B  “Tell your health care provider if you have gastric pain that does not subside.”
“Do not take the medication if you feel tired.”
“Take the medication on an empty stomach.”

C  “Your drug dose will be gradually increased.”
“Get up slowly from a sitting or lying position.”
“Tell your health care provider if you have gastric pain that does not subside.”

D  “Do not take the medication if you feel tired.”
“Take the medication on an empty stomach.”
“Your drug dose will be gradually increased.”

A  7 mg

B  10 mg

C  12 mg

D  18 mg

A  Inject bethanechol. Provide a high-fiber diet. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

B  Inject bethanechol. Provide a high-fiber diet. Administer a stool softener. Administer atropine. Increase fluid intake as tolerated.

C  Administer atropine. Provide a high-fiber diet. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

D  Inject bethanechol. Administer atropine. Administer a stool softener. Ambulate the patient as tolerated. Increase fluid intake as tolerated.

A  Hypoglycemia, Hypothyroidism, Dyspnea

B  Orthostatic hypotension, Hypoglycemia, Hypothyroidism

C  Dyspnea, Bronchoconstriction, Orthostatic hypotension

D  Bronchoconstriction, Hypoglycemia, Hypothyroidism

A  7 mg

B  5 mg

C  2 mg

D  10 mg

A  Gradual decrease in cognitive function

B  Cognitive stabilization for a few months

C  Temporary improvement in cognitive skills

D  Rapid cognitive changes with decline

A  Nicotinic-receptor stimulation causes increased blood pressure. Muscarinic-receptor stimulation causes increased gastrointestinal motility. Nicotinic-receptor stimulation causes increased contraction of skeletal muscle.

B  Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels. Nicotinic-receptor stimulation causes increased blood pressure.

C  Nicotinic-receptor stimulation causes increased contraction of skeletal muscle. Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels.

D  Nicotinic-receptor stimulation causes dilation of the pupils. Muscarinic-receptor stimulation causes constriction of blood vessels. Muscarinic-receptor stimulation causes increased gastrointestinal motility.

A  “Seek medical help if you develop nausea and vomiting.”

B  “Do not eat solid food.”

C  “Take the medication 30 minutes after eating.”

D  “Notify your health care provider if you have a headache.”

A  Asthma, Coronary artery disease

B  Hypothyroidism, Psoriatic arthritis.

C  Emphysema, Hypothyroidism

D  Emphysema, Psoriatic arthritis.

A  Gastrointestinal (GI) upset, Ataxia, Dyspnea

B  Insomnia, Hypotension, Gastrointestinal (GI) upset

C  Ataxia, Insomnia, Dyspnea

D  Ataxia, Dyspnea, Hypotension

A  “The medication has an onset of action of about 3 weeks.”

B  “Sometimes family members aren’t the best at assessing these things.”

C  “Let me assess what other medications the patient is taking.”

D  “I will call the health care provider and ask for the medication to be changed.”

A  Blood glucose level

B  Vital signs

C  Body mass index

D  Bowel sounds

A  Donepezil

B  Memantine

C  Rivastigmine

D  Galantamine

A  Take ibuprofen before rising.

B  Call for someone before rising.

C  Increase fluid intake to increase blood volume.

D  Move from a sitting to standing position slowly.

A  Memantine

B  Edrophonium

C  Bethanechol

D  Physostigmine

A  Blood pressure 150/95 mm Hg

B  Respiratory rate 24 breaths/min

C  Heart rate 30 beats/min

D  Constipation

A  “I have noticed that I have been urinating more frequently.”

B  “My family says that my memory has improved.”

C  “I can tell my muscle strength has gotten better.”

D  “I feel like I am coughing up more phlegm.”

A  “Do not take this medication with food.”

B  “Be cautious with activity until you know how the medication affects you.”

C  “Do not drink grapefruit juice while on this medication.”

D  “You will take this medication once per week.”

A  Donepezil, Neostigmine, Memantine

B  Physostigmine, Donepezil, Memantine

C  Donepezil, Memantine, Pyridostigmine

D  Neostigmine, Pyridostigmine, Physostigmine

A  Raised, erythematous rash

B  Blood pressure 70/40 mm Hg

C  Inability to sleep

D  Respiratory rate 30 breaths/min

A  Sweating, Dizziness, Dry cough, Hypotension

B  Sweating, Dizziness, Bradycardia, Hypotension

C  Dry cough, Dizziness, Bradycardia, Hypotension

D  Sweating, Dizziness, Bradycardia, Dry cough

A  An antihistamine intravenously

B  Physostigmine intravenously

C  A high dose of donepezil orally

D  Dextrose solution intravenously

A  Gastrointestinal

B  Neurologic

C  Musculoskeletal

D  Urinary

A  Galantamine and Edrophonium

B  Neostigmine and Galantamine

C  Neostigmine and Edrophonium

D  Pilocarpine and Succinylcholine

A  Wakefulness

B  Relaxed muscles

C  Increased cognition

D  Urination

A  Urinary retention

B  Hyperthyroidism

C  Chronic refractory heartburn

D  Gastric atony

A  Donepezil

B  Memantine

C  Bethanechol

D  Pyridostigmine

A  Intravenous

B  Intramuscular

C  Oral

D  Ocular

A  Administer epinephrine.

B  Monitor the patient’s heart rate.

C  Assess the patient’s breath sounds.

D  Measure the patient’s urinary output.

A  Cevimeline

B  Donepezil

C  Bethanechol

D  Succinylcholine

A  Rivastigmine

B  Epinephrine

C  Atropine

D  Memantine

A  Pilocarpine

B  Neostigmine

C  Rivastigmine

D  Succinylcholine

A  Pyridostigmine

B  Echothiophate

C  Atropine

D  Donepezil

A  Carbachol

B  Memantine

C  Tacrine

D  Physostigmine

A  Dry eye syndrome

B  Glaucoma

C  Macular degeneration

D  Cataracts

A  Donepezil

B  Memantine

C  Atropine

D  Rivastigmine

A  Urinary atony

B  Respiratory atelectasis

C  Postoperative hypotension

D  Postoperative ischemic colitis

A  Ability to swallow without difficulty

B  Decreased respiration

C  Ability to speak clearly

D  Increased arm strength

A  Limit sleep during the day

B  Add more stimuli to the environment

C  Increased responsibility for self-care

D  A walking program at least once a week

A  “The medical alert in my health care record should cover me.”

B  “I hope to feel improvement in muscle strength.”

C  “I will take the medication 30 minutes before meals.”

D  “I will review any over-the-counter medications with my health care provider.”

A  Atropine available for immediate use. Epinephrine available for immediate use. Electroencephalogram ready to place. Blood pressure equipment for frequent monitoring.

B  Atropine available for immediate use. Epinephrine available for immediate use. Telemetry monitor on the patient. Electroencephalogram ready to place.

C  Atropine available for immediate use. Epinephrine available for immediate use. Telemetry monitor on the patient.Blood pressure equipment for frequent monitoring.

D  Atropine available for immediate use. Electroencephalogram ready to place. Telemetry monitor on the patient. Blood pressure equipment for frequent monitoring.

A  Urinary retention and Hypoactive bowel sounds

B  Urinary retention and Dry mouth

C  Dry mouth and Hypoactive bowel sounds

D  Nausea and Apical pulse of 56 beats per minute

A  Subcutaneous infusions

B  Liquid oral solutions

C  Nasal spray

D  Oral disintegrating tablets